Related Experiment Video
Updated: Jun 26, 2026
04:44
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
[Respiratory involvement in systemic lupus erythematosus].
D Carmier1, S Marchand-Adam, P Diot
1Service de Pneumologie, CHRU et Université François Rabelais de Tours, France.
Revue Des Maladies Respiratoires
|December 25, 2008
Summary
Respiratory complications in systemic lupus erythematosus (SLE) are common but often overlooked. Early diagnosis and treatment of these diverse lung issues are vital for improving patient outcomes.
Area of Science:
- Immunology
- Pulmonology
- Rheumatology
Background:
- Respiratory involvement in systemic lupus erythematosus (SLE) is frequently underestimated compared to its cutaneous, rheumatological, and renal manifestations.
- Diagnosis can be challenging due to the varied anatomical and clinical presentations of lung involvement in SLE.
Purpose of the Study:
- To highlight the significance of respiratory involvement in SLE.
- To classify the diverse patterns of pulmonary manifestations in SLE.
- To emphasize the importance of accurate diagnosis for effective treatment.
Main Methods:
- Literature review and classification of respiratory manifestations in SLE based on anatomical location.
- Discussion of underlying pathological mechanisms including genetic, environmental, and immunological factors.
- Overview of current treatment strategies.
Main Results:
- Respiratory involvement in SLE can be categorized into five main groups: pleural, infiltrating pneumonia, airways, vascular, and muscular/diaphragmatic.
- Pathology involves complex interactions of genetic, endocrine, environmental, pharmacological, and immunological factors.
- Treatment modalities include steroids, immunosuppressants, and plasmapheresis, tailored to the specific manifestation and severity.
Conclusions:
- Respiratory manifestations are a significant and diverse aspect of SLE that require careful diagnosis.
- Prompt and accurate diagnosis is crucial for initiating appropriate treatment and improving prognosis.
- Advances in immunosuppressive therapies offer improved outcomes for patients with SLE-related lung disease.
More Related Videos
Related Concept Videos
01:29Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
01:17Other Pulmonary Disorders
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
01:23Assessment of Respiration
The respiratory system's basic structures and primary functions lay the foundation for nurses' comprehensive respiratory assessments. This assessment includes subjective and objective data to gauge the patient's respiratory health.
Subjective Assessment: Nurses interview the patient to gather information directly during the subjective assessment. It includes questions about the individual's medical history, medications, and symptoms, focusing on past respiratory conditions like asthma or COPD,...
Subjective Assessment: Nurses interview the patient to gather information directly during the subjective assessment. It includes questions about the individual's medical history, medications, and symptoms, focusing on past respiratory conditions like asthma or COPD,...